T. Rowe Price Investment Management, Inc. Neogenomics Inc Transaction History
T. Rowe Price Investment Management, Inc.
- $163 Billion
- Q1 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 6,857,581 shares of NEO stock, worth $94 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
6,857,581
Previous 6,382,515
7.44%
Holding current value
$94 Million
Previous $103 Million
4.39%
% of portfolio
0.07%
Previous 0.07%
Shares
7 transactions
Others Institutions Holding NEO
# of Institutions
279Shares Held
127MCall Options Held
1.13MPut Options Held
232K-
Black Rock Inc. New York, NY19.9MShares$272 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$195 Million0.0% of portfolio
-
Brown Advisory Inc9.67MShares$133 Million0.21% of portfolio
-
Janus Henderson Group PLC London, X06.28MShares$86.1 Million0.06% of portfolio
-
State Street Corp Boston, MA4.9MShares$67.1 Million0.0% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.72B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...